Extended Data Table 2 Pattern of recurrence

From: Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial

  1. aFor patients who had multiple recurrences identified on the same day, the most serious type is tabulated according to the displayed prespecified hierarchy.
Back to article page